Compounds > celivarone
Page last updated: 2024-09-05

celivarone and Auricular Fibrillation

celivarone has been researched along with Auricular Fibrillation in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arya, A; Camm, AJ; Milner, P; Silberbauer, J; Sulke, N; Teichman, SL1
Verma, A1
Aliot, EM; Capucci, A; Connolly, SJ; Crijns, H; Hohnloser, SH; Khitri, AR; Kowey, PR; Kulakowski, P; Radzik, D; Roy, D1
Cosnier-Pucheu, S; Djandjighian, L; Gautier, P; Herbert, JM; Nisato, D; Roccon, A; Serre, M1
Banchs, JE; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, E; Samii, S; Wolbrette, DL1

Reviews

1 review(s) available for celivarone and Auricular Fibrillation

ArticleYear
New antiarrhythmic treatment of atrial fibrillation.
    Expert review of cardiovascular therapy, 2007, Volume: 5, Issue:4

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Carvedilol; Cyclopropanes; Dronedarone; Fatty Acids, Omega-3; Furans; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oligopeptides; Organic Chemicals; Peptidyl-Dipeptidase A; Potassium Channel Blockers; Propanolamines; Purinergic P1 Receptor Agonists

2007

Trials

2 trial(s) available for celivarone and Auricular Fibrillation

ArticleYear
A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:4

    Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Combined Modality Therapy; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Middle Aged; Pacemaker, Artificial; Prospective Studies; Treatment Outcome

2009
Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
    Journal of cardiovascular electrophysiology, 2012, Volume: 23, Issue:5

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Benzofurans; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Heart Conduction System; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2012

Other Studies

2 other study(ies) available for celivarone and Auricular Fibrillation

ArticleYear
Alternatives to amiodarone: search for the Holy Grail.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2009, Volume: 11, Issue:4

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Combined Modality Therapy; Dose-Response Relationship, Drug; Dronedarone; Humans; Pacemaker, Artificial; Phenethylamines; Sulfonamides

2009
In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias.
    Journal of cardiovascular pharmacology, 2005, Volume: 45, Issue:2

    Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Death, Sudden, Cardiac; Dogs; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Injections, Intravenous; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Potassium; Rats; Rats, Sprague-Dawley; Vagus Nerve; Ventricular Dysfunction

2005